Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Amicus Therapeutics Inc (NASDAQ:FOLD)

17.19
Delayed Data
As of Jul 31
 +0.80 / +4.88%
Today’s Change
3.92
Today|||52-Week Range
17.42
+106.61%
Year-to-Date

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for Amicus Therapeutics Inc have a median target of 16.00, with a high estimate of 19.00 and a low estimate of 15.00. The median estimate represents a -6.92% decrease from the last price of 17.19.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Buy stock in Amicus Therapeutics Inc. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.24
Sales
$0.00
Reporting Date
Aug 05

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 3.00%
 
 
 
 
 
 
Growthannually -12.90%
 
 
 
 
 
 

Sales

Growthquarterly --
 
 
 
 
 
 
Growthannually -100.00%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.